𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improvement of spontaneous speech in early stage Alzheimer’s disease with rivastigmine

✍ Scribed by E. G. Visch-Brink; W. Van Rhee-Temme; T. Rietveld; J. W. M. Krulder; F. Van Harskamp; T. J. M. Van Der Cammen

Book ID
107669774
Publisher
Springer
Year
2009
Tongue
English
Weight
87 KB
Volume
13
Category
Article
ISSN
1279-7707

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of rivastigmine in subjects wit
Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease
✍ A. Burns; R. Spiegel; P. Quarg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## Background Cholinesterase (ChE) inhibitors are primarily used in the treatment of mild to moderate Alzheimer's disease (AD), but may also be effective in more severe disease. ## Objective To evaluate the dual ChE inhibitor, rivastigmine, in more severe dementia. ## Methods We re

Rivastigmine transdermal patch and capsu
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy
✍ Martin R. Farlow; George T. Grossberg; Xiangyi Meng; Jason Olin; Monique Somogyi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

## Abstract ## Objectives The cholinesterase inhibitor rivastigmine is approved for the symptomatic treatment of mild to moderate Alzheimer's disease (AD). This exploratory, hypothesis‐forming analysis assessed response to rivastigmine according to severity of dementia at baseline. ## Methods Th